©The Author(s) 2026.
World J Clin Cases. Jan 26, 2026; 14(3): 114521
Published online Jan 26, 2026. doi: 10.12998/wjcc.v14.i3.114521
Published online Jan 26, 2026. doi: 10.12998/wjcc.v14.i3.114521
Table 4 Consolidated efficacy summary of major postdural puncture headache interventions
| Ref. | Intervention | Primary use | Efficacy for PDPH prevention | Efficacy for PDPH treatment | Key findings and notes | Common/notable side effects |
| Alatni et al[3], 2024; Barati-Boldaji et al[16], 2023 | Aminophylline/theophylline | Treatment and prevention | Mixed (not recommended): A meta-analysis found no significant benefit of prophylaxis (very low evidence) | Effective (recommended): Significantly reduced pain scores (moderate evidence); this effect is enhanced when combined with dexamethasone | Considered a primary pharmacological option for treating established PDPH; the efficacy of prevention is not well supported | No significant adverse events were reported in the studies |
| Basurto Ona et al[15], 2015 | Caffeine | Treatment | It is not typically used for prevention | Effective (recommended): Reduces the persistence of PDPH and the need for rescue interventions compared to placebo | A classic and well-established treatment for PDPH | Well tolerated; no major side effects were reported in the review |
| Alatni et al[3], 2024; Basurto Ona et al[15], 2015; Zhao et al[19], 2023 | Gabapentin/pregabalin | Treatment and prevention | Effective (potential): Pregabalin has a preventive effect; gabapentin/pregabalin reduced incidence at 48 hours | Effective (recommended): Superior to placebo and ergotamine + caffeine in reducing pain scores over several days | Oral pregabalin has been highlighted as being particularly effective for both treatment and prevention | Generally well tolerated; sedation was mentioned but not quantitatively synthesized |
| Zhao et al[19], 2023 | Ondansetron (OND) | Prevention | Effective (recommended): Significantly reduces the cumulative incidence of PDPH | Not assessed for treatment in these reviews | It also significantly reduces the incidence of postoperative nausea and vomiting (PONV) | It may induce migraine headaches in patients with a history of migraine (case reports) |
| Zhao et al[19], 2023 | Propofol (PPF) | Prevention | Most effective (recommended): Ranked as the most effective prophylactic drug for reducing incidence | Not assessed for treatment in these reviews | Also significantly reduces the incidence of postoperative nausea and vomiting (PONV) | Sedation, diplopia, and tinnitus were mentioned in individual studies |
| Basurto Ona et al[15], 2015; Zhao et al[19], 2023 | Corticosteroids (dexamethasone, hydrocortisone) | Treatment and prevention | Not effective: Dexamethasone did not show superiority in prevention (hydrocortisone did not show any significant prophylactic effects) | Effective for treatment: Hydrocortisone (IV) combined with conventional treatment led to better pain scores | Hydrocortisone is effective for treatment but not for prevention; the utility of dexamethasone remains questionable | No clinically significant adverse events were reported |
| Chang et al[17], 2021 | Greater occipital nerve block (GONB) | Treatment | N/A | Effective (recommended): Provides significant short-term pain relief (1 hour, 6 hours, 24 hours) and reduces intervention failure | A feasible, less invasive alternative to EBP; steroid coadministration may prolong analgesic effects | No major adverse events were reported. Minor local discomfort |
| Dwivedi et al[20], 2023 | Sphenopalatine ganglion block (SPGB) | Treatment | N/A | Effective (short-term): Superior to conservative care for immediate pain relief (up to 6 hours); not superior to sham or GONB | The effects are immediate but short-lived; it was not superior to the other nerve blocks | Nasal discomfort, throat numbness, and unpleasant taste (minor and transient) |
| Alatni et al[3], 2024 | Epidural blood patch (EBP) | Treatment | N/A | Highly effective (gold standard): The ultimate solution for patients failing medical therapy | It rapidly decreases headache intensity; approximately 20% may require a second procedure; it is more invasive than pharmacological or nerve block options | Risks associated with neuraxial procedures (e.g., infection, repeat dural puncture) |
| Alatni et al[3], 2024 | Fibrin glue | Prevention | Effective (promising): Significantly reduced PDPH incidence and duration in the reviewed evidence | N/A | A novel preventive strategy has been noted for its promising safety and affordability | Not explicitly stated; however, the reviewed evidence noted a good safety profile |
- Citation: Mahanty PR, Sen B, Anand R, Nag DS, Pahadi N, Lodh D, Upadhyaya T. Sphenopalatine ganglion block for postdural puncture headache: A review of current evidence. World J Clin Cases 2026; 14(3): 114521
- URL: https://www.wjgnet.com/2307-8960/full/v14/i3/114521.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v14.i3.114521